Novadip Biosciences raises $31.3 mln
Novadip Biosciences said Thursday it raised a 28 million Euro (US$31.3 mln) round of financing led by New Science Ventures. Belgian investors VIVES Louvain Technology Fund, NivelInvest (Start-Up), Fund+, Integrale, SRIW, SFPI-FPIM, Epimède and several individual investors also took part. Novadip Biosciences isthe biopharmaceutical spin-off company of Université catholique de Louvain.
10 September 2015•8 mins read
